NFKB1 and hepatocellular carcinoma: Hu et al. also discovered that AST reduces the binding activity of NF-κB to DNA and promotes the activity of ERK1/2, thereby regulating the NF-κB/ERK signaling pathway and inducing an apoptotic cascade in HCC.